Background and aims: Nocturnal enuresis is psychosocially detrimental to children affected by it. First-line treatment involves offering emotional support and promoting appropriate voiding patterns.

The evidence-based management of enuresis in children includes desmopressin and enuresis alarms (level 1, grade A recommendation), and existing data suggest that alarm therapy with practitioner ...

Intranasal desmopressin (DDAVP, DDVP, Minirin, Stimate Nasal Spray) is no longer indicated for primary nocturnal enuresis and is associated with an increased risk of severe hyponatremia (possibly ...

Desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus, and for the management of primary nocturnal enuresis. Aurobindo has ...

WASHINGTON The Food and Drug Administration has notified health care professionals and patients of its request that manufacturers update the prescribing information for desmopressin. Desmopressin ...

ROCKVILLE, Md., Dec.4, 2007-- FDA notified healthcare professionals and patients of the Agency's request that manufacturers update the prescribing information for desmopressin to include important new ...

Your son is more likely to wet the bed if you did. It is a common problem - at least one in twenty children, more often boys, still wet the bed by the age of ten. Fortunately he should also grow out ...

Feb. 18, 2005 — The U.S. Food and Drug Administration (FDA) has approved a first-time generic formulation of terconazole vaginal cream 0.4% for the treatment of vulvovaginal candidiasis; a first-time ...